| Title |
A combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex
|
|---|---|
| Published in |
Biologics: Targets & Therapy, February 2011
|
| DOI | 10.2147/btt.s12535 |
| Pubmed ID | |
| Authors |
Stephen P Myers, Joan O’Connor, J Helen Fitton, Lyndon Brooks, Margaret Rolfe, Paul Connellan, Hans Wohlmuth, Phil A Cheras, Carol Morris |
| Abstract |
Isolated fucoidans from brown marine algae have been shown to have a range of immune-modulating effects. This exploratory study aimed to determine whether a seaweed nutrient complex containing a blend of extracts from three different species of brown algae plus nutrients is safe to administer and has biological potential as an immune modulator. The study was undertaken as an open-label combined Phase I and II study. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Indonesia | 1 | 1% |
| New Zealand | 1 | 1% |
| Portugal | 1 | 1% |
| France | 1 | 1% |
| Unknown | 91 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 20 | 21% |
| Student > Bachelor | 12 | 13% |
| Student > Master | 10 | 11% |
| Student > Ph. D. Student | 9 | 9% |
| Student > Doctoral Student | 7 | 7% |
| Other | 20 | 21% |
| Unknown | 17 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 27 | 28% |
| Medicine and Dentistry | 12 | 13% |
| Biochemistry, Genetics and Molecular Biology | 8 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 8% |
| Chemistry | 4 | 4% |
| Other | 14 | 15% |
| Unknown | 22 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 34. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 December 2023.
All research outputs
#1,176,086
of 25,373,627 outputs
Outputs from Biologics: Targets & Therapy
#3
of 284 outputs
Outputs of similar age
#5,697
of 193,461 outputs
Outputs of similar age from Biologics: Targets & Therapy
#1
of 2 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,461 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them